Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:23 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 127 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Heart Transplant Surgery Clear all

Conditions: Coronary Artery Bypass Grafting, Open Heart Surgery, Aortic Surgery or Redo Surgery, On-pump Double or Triple Valve Procedures
Interventions: Open Heart Surgery; Procedure
Lead sponsor: LifeBridge Health; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Transplant; Failure, Heart, Heart Failure, Congestive, Lung Transplant Failure
Interventions: Not listed
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 168 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Saphenous Vein Graft Disease
Interventions: Aspirin, Ticagrelor; Drug
Lead sponsor: Boca Raton Regional Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Boca Raton, Florida

Conditions: Patients Undergoing Elective Coronary Artery Bypass Graft
Interventions: Lansoprazole; Drug
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Coronary Artery Diseases, Valvular Heart Diseases
Interventions: Reiki/manual therapy; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 272 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Coronary Heart Disease, Graft Occlusion, Vascular
Interventions: Placebo, RO4905417; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 27
States / cities: Huntsville, Alabama • Tucson, Arizona • Los Angeles, California + 21 more

Conditions: Coronary Artery Bypass, Thrombosis
Interventions: Not listed
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 90 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Coronary Artery Stenosis, Myocardial Revascularization, Myocardial Ischemia
Interventions: Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting; Procedure
Lead sponsor: Ministry of Science and Higher Education, Poland; Government
Eligibility: 18 Years to 80 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 2
States / cities: Bryn Mawr, Pennsylvania • San Antonio, Texas

Conditions: CABG Graft Integrity, CABG, Blood Flow, Transit-time Flow Measurement, Heart Disease
Interventions: Transit-Time Flow Measurement (TTFM); Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 1,242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: New York, New York

Conditions: Heart Failure
Interventions: AZD8601, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Heart Failure
Interventions: Nitric Oxide, Prostacyclin; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Stanford, California

Conditions: Coronary Artery Disease
Interventions: Hybrid Coronary Revascularization (HCR), Coronary Artery Bypass Grafting (CABG); Procedure
Lead sponsor: Emory University; Other
Eligibility: Not listed
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Heart Disease, Ischemic Heart Disease, Coronary Artery Disease, Coronary Artery Disease (CAD)
Interventions: Cell Therapy; Other
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Glycemic Control
Interventions: IV Insulin drip, Insulin; Drug
Lead sponsor: American Heart Association; Other
Eligibility: 18 Years to 90 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease
Interventions: Coronary artery bypass grafting (CABG), Percutaneous coronary intervention (PCI); Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2039
U.S. locations: 18
States / cities: Glendale, California • Atlanta, Georgia • Carmel, Indiana + 12 more

Conditions: Atrial Fibrillation
Interventions: Omega Three Polyunsaturated fatty acids; Drug
Lead sponsor: Chirag Sandesara; Other
Eligibility: 18 Years to 85 Years
Enrollment: 260 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Coronary Artery Bypass Graft Surgery Patients
Interventions: Mean arterial pressure during cardiopulmonary bypass 80 mmHg vs. customized; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 35 Years to 89 Years
Enrollment: 412 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 1999
U.S. locations: 1
States / cities: New York, New York

Conditions: Tricuspid Regurgitation, Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Interventions: Left ventricular assist device (LVAD), Tricuspid Valve Repair (TVR); Device · Procedure
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Surgery, Coronary Artery Disease
Interventions: Rocuronium, Neostigmine, Glycopyrrolate, Sugammadex; Drug
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Poor Glycemic Control
Interventions: Metformin, Glargine insulin, Glulisine; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: This Study is Being Conducted to Collect Echocardiographic Data to Test the Lumify Ultrasound With Hemodynamic Automation Device
Interventions: Ultrasound imaging; Diagnostic Test
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Frail Elderly, Coronary Artery Disease
Interventions: Off-pump coronary-artery bypass grafting, On-pump coronary-artery bypass grafting; Other
Lead sponsor: University of Sao Paulo General Hospital; Other
Eligibility: 60 Years and older
Enrollment: 440 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Coronary Artery Bypass Graft
Interventions: Hemodynamic monitoring; Device
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Coronary Disease, Heart Valve Diseases
Interventions: CTI-01 (ethyl pyruvate); Drug
Lead sponsor: Critical Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 17
States / cities: Laguna Hills, California • Los Angeles, California • San Francisco, California + 14 more

Search by objective public record fields.

Assessment of Platelet Function in Patients Undergoing Open Heart Surgery

Utilizing Technology for Optimization of Pain Management and Mobilization in High Risk Cardiac Surgical ICU Patients

Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis

Lansoprazole Preventing Gastroduodenal Stress Ulcerations

Clinical and Hospital Stay Effects of Reiki and Manual Therapy After Open Heart Surgery

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Evaluating the Role of Thrombin in Saphenous Vein Graft Failure After Heart Bypass Surgery

Study of Unprotected Left Main Stenting Versus Bypass Surgery (LE MANS Study)

The Relationship Between Blood Flow Readings During Surgery and How Well the Graft Stays Open and How Patients Recover Afterward in Coronary Artery Bypass Graft Surgery

AZD8601 Study in CABG Patients

Inhaled Nitric Oxide and Inhaled Prostacyclin After Cardiac Surgery for Heart Transplant or LVAD Placement

HCR vs. CABG Study

Stem Cell Injection to Treat Heart Damage During Open Heart Surgery

Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery

Improving Outcomes and Quality of Life After CABG

Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients

Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery

Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients

Testing Automated Echocardiography

Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients

Prospective Data Analysis of a Quality Improvement Initiative in High Risk Cardiac Surgery Patients

CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)